Share / Export Citation / Email / Print / Text size:

Postępy Mikrobiologii - Advancements of Microbiology

Polish Society of Microbiologists

Subject: Microbiology


ISSN: 0079-4252
eISSN: 2545-3149





Volume / Issue / page

Related articles

VOLUME 57 , ISSUE 3 (April 2018) > List of articles


Renata Welc-Falęciak * / Małgorzata Bednarska / Magdalena Szatan / Agnieszka Pawełczyk

Keywords : Babesia, Borrelia, HIV, Rickettsia

Citation Information : Postępy Mikrobiologii - Advancements of Microbiology. Volume 57, Issue 3, Pages 251-259, DOI: https://doi.org/10.21307/PM-2018.57.3.251

License : (CC BY-NC-ND 4.0)

Published Online: 23-May-2019



The studies on the occurrence and diversity of tick-borne infections in HIV-infected individuals have been few, and the subject has been relatively neglected when compared with other infections associated with HIV. Non-specific symptoms of tick-borne diseases pose a challenge in clinical care and may lead to misdiagnosis, especially in HIV-positive patients, who often experience many non-specific clinical symptoms. Additionally, in immunocompromised patients, a significant delay of antibody production may occur, and the results of a serological test may be misinterpreted. This review focuses on the most common tick-borne infections in HIV-positive patients in Europe.

Content not available PDF Share



1. Aguero-Rosenfeld M.E., Wang G., Schwartz I., Wormser G.P.: Diagnosis of lyme borreliosis. Clin. Microbiol. Rev. 18, 484–509 (2005)

2. Aguilar-Delfin I., Wettstein P.J., Persing D.H.: Resistance to acute babesiosis is associated with interleukin-12- and gamma interferon-mediated responses and requires macrophages and natural killer cells. Infect. Immun. 71, 2002–2008 (2003)

3. Alemu A., Shiferaw Y., Addis Z., Mathewos B., Birhan W.: Effect of malaria on HIV/AIDS transmission and progression. Parasit. Vectors, 6, 18 (2013)

4. Bakken J.S., Dumler J.S.: Human granulocytic anaplasmosis. Infect. Dis. Clin. North. Am. 29, 341–355 (2015)

5. Barrio J., de Diego A., Ripoll C., Perez-Calle J.L., Núñez O., Salcedo M., Clemente G.: Mediterranean spotted fever in liver transplantation: a case report. Transplant Proc. 34, 1255–1256 (2002)

6. Barthold S.W., Sidman C.L., Smith A.L.: Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am. J. Trop. Med. Hyg. 47, 605–613 (1992)

7. Bell J.E.: An update on the neuropathology of HIV in the HAART era. Histopathology, 45, 549–559 (2004)

8. Benezra D., Brown A.E., Polsky B., Gold J.W., Armstrong D.: Babesiosis and infection with human immunodeficiency virus (HIV). Ann. Intern. Med. 107, 944 (1987)

9. Biernat B., Stańczak J., Michalik J., Sikora B., Cieniuch S.: Rickettsia helvetica and R. monacensis infections in immature Ixodes ricinus ticks derived from sylvatic passerine birds in west-central Poland. Parasitol. Res. 115, 3469–3477 (2016)

10. Blatz R., Kühn H.J., Hermann W., Rytter M., Rodloff A.C.: Neurosyphilis and neuroborreliosis. Retrospective evaluation of 22 cases. Nervenarzt. 76, 724–732 (2005)

11. Bloch E.M., Lee T.H., Krause P.J., Telford S.R. 3rd, Montalvo L., Chafets D., Usmani-Brown S., Lepore T.J., Busch M.P.: Development of a real-time polymerase chain reaction assay for sensitive detection and quantitation of Babesia microti infection. Transfusion, 53, 2299–2306 (2013)

12. Bockenstedt L.K., Kang I., Chang C., Persing D., Hayday A., Barthold S.W.: CD4+ T helper 1 cells facilitate regression of murine Lyme carditis. Infect. Immun. 69, 5264–5269 (2001)

13. Bremell D., Säll C., Gisslén M., Hagberg L.: Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review. J. Med. Case. Rep. 5, 465 (2011)

14. Brouqui P., Parola P., Fournier P.E., Raoult D.: Spotted fever rickettsioses in southern and eastern Europe. FEMS Immunol. Med. Microbiol. 49, 2–12 (2007)

15. Buczek A., Ciura D., Bartosik K., Zając Z., Kulisz J.: Threat of attacks of Ixodes ricinus ticks (Ixodida: Ixodidae) and Lyme borreliosis within urban heat islands in south-western Poland. Parasit. Vectors, 7, 562 (2014)

16. Centers of Disease Control and Prevention, CDC, Laboratory Identification of Parasitic Diseases of Public Health Concern, https://www.cdc.gov/dpdx/babesiosis/dx.html (styczeń 2018 r.)

17. Centers of Disease Control and Prevention, CDC, Surveillance for Babesiosis - United States, 2014,https://www.cdc.gov/parasites/babesiosis/resources/babesiosis_surveillance_summary_2016.pdf (styczeń 2018 r.)

18. Cerný R., Machala L., Bojar M., Rozsypal H., Pícha D.: Neuroborreliosis in an HIV-1 positive patient. Infection, 34, 100–102 (2006)

19. Cetin E., Sotoudeh M., Auer H., Stanek G.: Paradigm Burgenland: risk of Borrelia burgdorferi sensu lato infection indica-
ted by variable seroprevalence rates in hunters. Wien. Klin. Wochenschr. 118, 677–681 (2006)

20. Chang C.C., Crane M., Zhou J., Mina M., Post J.J., Cameron B.A., Lloyd A.R., Jaworowski A., French M.A., Lewin S.R.: HIV and co-infections. Immunol. Rev. 254, 114–142 (2013)

21. Chmielewski T., Podsiadly E., Karbowiak G., Tylewska-Wierzbanowska S.: Rickettsia spp. in ticks, Poland. Emerg. Infect. Dis. 15, 486–488 (2009)

22. Cisak E., Wójcik-Fatla A., Stojek N., Chmielewska-Badora J., Zwoliński J., Buczek A., Dutkiewicz J.: Prevalence of Borrelia burgdorferi genospecies in Ixodes ricinus ticks from Lublin region (eastern Poland). Ann. Agric. Environ. Med. 13, 301–306 (2006)

23. Clawson M.L., Paciorkowski N., Rajan T.V., La Vake C., Pope C., La Vake M., Wikel S.K., Krause P.J., Radolf J.D.: Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB/c mice. Infect. Immun. 70, 5304–5306 (2002)

24. Colomba C., Saporito L., Colletti P., Mazzola G., Rubino R., Pampinella D., Titone L.: Atrial fibrillation in Mediterranean spotted fever. J. Med. Microbiol. 57, 1424–1426 (2008)

25. Colomba C., Saporito L., Siracusa L., Giammanco G., Bonura S., Titone L.: Mediterranean spotted fever in paediatric and adult patients: two clinical aspects of the same disease. Infez. Med. 19, 248–253 (2011)

26. Colomba C., Siracusa L., Madonia S., Saporito L., Bonura C., De Grazia S., Giammanco G.M.: A case of spotted fever rickettsiosis in a human immunodeficiency virus-positive patient. J. Med. Microbiol. 62, 1363–1364 (2013)

27. Cook M.J., Puri B.K.: Application of Bayesian decision-making to laboratory testing for Lyme disease and comparison with testing for HIV. Int. J. Gen. Med. 10, 113–123 (2017)

28. Cordoliani F., Vignon-Pennamen M.D., Assous M.V., Vabres P., Dronne P., Rybojad M., Morel P.: Atypical Lyme borreliosis in an HIV-infected man. Br. J. Dermatol. 137, 437–439 (1997)

29. Daniel M., Materna J., Honig V., Metelka L., Danielová V., Harcarik J., Kliegrová S., Grubhoffer L.: Vertical distribution of the tick Ixodes ricinus and tick-borne pathogens in the northern Moravian mountains correlated with climate warming (Jeseníky Mts., Czech Republic). Cent. Eur. J. Public Health, 17, 139–145 (2009)

30. de Sousa R., Walker D.H. i wsp.: Host- and microbe-related risk factors for and pathophysiology of fatal Rickettsia conorii infection in Portuguese patients. J. Infect. Dis. 198, 576–585 (2008)

31. Dunaj J., Moniuszko A., Zajkowska J., Pancewicz S.: The role of PCR in diagnostics of Lyme borreliosis. Przegl. Epidemiol. 67, 35–39 (2013)

32. Falagas M.E., Klempner M.S.: Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin. Infect. Dis. 22, 809–812 (1996)

33. Fang R., Blanton L.S., Walker D.H.: Rickettsiae as Emerging Infectious Agents. Clin. Lab. Med. 37, 383–400 (2017)

34. Froberg M.K., Dannen D., Bakken J.S.: Babesiosis and HIV. Lancet, 363, 704 (2004)

35. Gabrielli S., Galuppi R., Marcer F., Marini C., Tampieri M.P., Moretti A., Pietrobelli M., Cancrini G.:Development of culture-based serological assays to diagnose Babesia divergens infections. Vector Borne Zoonotic Dis. 12, 106–110 (2012)

36. Giammanco G.M., Vitale G., Mansueto S., Capra G., Caleca M.P., Ammatuna P.: Presence of Rickettsia conorii subsp. israelensis, the causative agent of Israeli spotted fever, in Sicily, Italy, ascertained in a retrospective study. J. Clin. Microbiol. 43, 6027–6031 (2005)

37. González L.M., Castro E., Lobo C.A., Richart A., Ramiro R., González-Camacho F., Luque D., Velasco A.C., Montero E.: First report of Babesia divergens infection in an HIV patient. Int. J. Infect. Dis. 33, 202–204 (2015)

38. Gubernot D.M., Lucey C.T., Lee K.C., Conley G.B., Holness L.G., Wise R.P.: Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997–2007. Clin. Infect. Dis. 48, 25–30 (2009)

39. Hildebrandt A., Gray J.S., Hunfeld K.P.: Human babesiosis in Europe: what clinicians need to know. Infection, 41, 1057–1072 (2013)

40. Hubálek Z.: Epidemiology of lyme borreliosis. Curr. Probl. Dermatol. 37, 31–50 (2009)

41. Hunfeld K.P., Hildebrandt A., Gray J.S.: Babesiosis: recent insights into an ancient disease. Int. J. Parasitol. 38, 1219–1237 (2008)

42. Hunfeld K.P., Lambert A., Kampen H., Albert S., Epe C., Brade V., Tenter A.M.: Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany. J. Clin. Microbiol. 40, 2431–2436 (2002)

43. Igarashi I., Toyoda Y. i wsp.: Roles of CD4(+) T cells and gamma interferon in protective immunity against Babesia microti infection in mice. Infect. Immun. 67, 4143–4148 (1999)

44. Jaenson T.G.1, Jaenson D.G., Eisen L., Petersson E., Lindgren E.: Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden. Parasit. Vectors, 5, 8 (2012)

45. Jones K.E., Patel N.G., Levy M.A., Storeygard A., Balk D., Gittleman J.L., Daszak P.: Global trends in emerging infectious diseases. Nature, 451, 990–993 (2008)

46. Jore S., Viljugrein H., Hofshagen M., Brun-Hansen H., Kristoffersen A.B., Nygård K., Brun E., Ottesen P., Sævik B.K., Ytrehus B.: Multi-source analysis reveals latitudinal and altitudinal shifts in range of Ixodes ricinus at its northern distribution limit. Parasit. Vectors, 4, 84 (2011)

47. Karp C.L., Auwaerter P.G.: Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens. Clin. Infect. Dis. 45, 1208–1213 (2007)

48. Karp G., Schlaeffer F., Jotkowitz A., Riesenberg K.: Syphilis and HIV co-infection. Eur. J. Intern. Med. 20, 9–13 (2009)

49. Kiewra D., Stańczak J., Richter M.: Ixodes ricinus ticks (Acari, Ixodidae) as a vector of Borrelia burgdorferi sensu lato and Borrelia miyamotoi in Lower Silesia, Poland-preliminary study. Ticks Tick Borne Dis. 5, 892–897 (2014)

50. Kowalec M., Szewczyk T., Welc-Falęciak R., Siński E., Karbowiak G., Bajer A.: Ticks and the city – are there any differences between city parks and natural forests in terms of tick abundance and prevalence of spirochaetes? Parasit. Vectors, 10, 573 (2017)

51. Krause P.J., Persing D.H. i wsp.: Persistent parasitemia after acute babesiosis. N. Engl. J. Med. 339, 160–165 (1998)

52. Krause P.J., Spielman A. i wsp.: Persistent and relapsing babesiosis in immunocompromised patients. Clin. Infect. Dis. 46, 370–376 (2008)

53. Léger E., Vourc’h G., Vial L., Chevillon C., McCoy K.D.: Changing distributions of ticks: causes and consequences. Exp. Appl. Acarol. 59, 219–244 (2013)

54. Levin A.E., Krause P.J.: Transfusion-transmitted babesiosis: is it time to screen the blood supply? Curr. Opin. Hematol. 23, 573–580 (2016)

55. Luce-Fedrow A., Mullins K., Kostik A.P., St John H.K., Jiang J., Richards A.L.: Strategies for detecting rickettsiae and diagnosing rickettsial diseases. Future Microbiol. 10, 537–564 (2015)

56. Machtinger L., Telford S.R. 3rd, Inducil C., Klapper E., Pepkowitz S.H., Goldfinger D.: Treatment of babesiosis by red blood cell exchange in an HIV-positive, splenectomized patient. J. Clin. Apher. 8, 78–81 (1993)

57. Mansueto P., Vitale G., Cascio A., Seidita A., Pepe I., Carroccio A., di Rosa S., Rini G.B., Cillari E., Walker D.H.: New insight into immunity and immunopathology of Rickettsial diseases. Clin. Dev. Immunol. 2012, 967852 (2012)

58. Mavilio D, Fauci AS. i wsp.: Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl. Acad. Sci. U S A, 102, 2886–2891 (2005)

59. Medlock J.M., Van Bortel W. i wsp.: Driving forces for changes in geographical distribution of Ixodes ricinus ticks in Europe. Parasit. Vectors, 6, 1 (2013)

60. Ministerstwo Zdrowia, Program Zdrowotny ‘Leczenie antyretrowirusowe osób żyjących z HIV w Polsce w latach 2017–2021’, http://www.mz.gov.pl/wpcontent/uploads/2017/11/nowy-program-arv-2017-2021-aktualizacja.pdf (styczeń 2018 r.)

61. Morens D.M., Folkers G.K., Fauci A.S.: The challenge of emerging and re-emerging infectious diseases. Nature, 430, 242–924 (2004)

62. Narodowy Instytutu Zdrowia Publicznego-Państwowy Zakład Higieny: Zachorowania na wybrane choroby zakaźne w Polsce od 1 stycznia do 31 grudnia 2017 r. oraz w porównywalnym okresie 2016 r., http://wwwold.pzh.gov.pl/oldpage/epimeld/2017/INF_17_12B.pdf (styczeń 2018 r.)

63. Ong K.R., Stavropoulos C., Inada Y.: Babesiosis, asplenia, and AIDS. Lancet, 336, 112 (1990)

64. Oteo J.A., Portillo A.: Tick-borne rickettsioses in Europe. Ticks Tick Borne Dis. 3, 271–278 (2012)

65. Pancewicz S.A., Garlicki A.M., Moniuszko-Malinowska A., Zajkowska J., Kondrusik M., Grygorczuk S., Czupryna P., Dunaj J.: Diagnostyka i leczenie chorób przenoszonych przez kleszcze. Rekomendacje polskiego towarzystwa epidemiologów i lekarzy chorób zakaźnych. Przegl. Epidemiol. 69, 421–428 (2015)

66. Paris D.H., Dumler J.S.: State of the art of diagnosis of rickettsial diseases: the use of blood specimens for diagnosis of scrub typhus, spotted fever group rickettsiosis, and murine typhus. Curr. Opin. Infect. Dis. 29, 433–439 (2016)

67. Pfäffle M., Littwin N., Muders S.V., Petney T.N.: The ecology of tick-borne diseases. Int. J. Parasitol. 43, 1059–1077 (2013)

68. Pogłód R., Rosiek A., Siński E., Łętowska M.: Choroby odkleszczowe w aspekcie bezpiecznego krwiodawstwa. J. Transf. Med. 4, 4–22 (2011)

69. Raoult D., Hechemy K.E., Baranton G.: Cross-reaction with Borrelia burgdorferi antigen of sera from patients with human immunodeficiency virus infection, syphilis, and leptospirosis. J. Clin. Microbiol. 27, 2152–2155 (1989)

70. Richards A.L.: Worldwide detection and identification of new and old rickettsiae and rickettsial diseases. FEMS Immunol. Med. Microbiol. 64, 107–110 (2012)

71. Rolfs R.T., Larsen S. i wsp.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N. Engl. J. Med. 33, 307–314 (1997)

72. Sadkowska-Todys M., Paradowska-Stankiewicz I., Rosińska M., Czarkowski M.P.: Zakażenia ludzkim wirusem upośledzenia odporności (HIV) (w) Sytuacja zdrowotna ludności Polski i jej uwarunkowania, red. Wojtyniak B., Goryński P., Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny, Warszawa, 2016, s. 200–203.

73. Saporito L., Giammanco G.M., Rubino R., Ingrassia D., Spicola D., Titone L., Colomba C.: Severe Mediterranean spotted fever complicated by acute renal failure and herpetic oesophagitis. J. Med. Microbiol. 59, 990–992 (2010)

74. Schacker T., Collier A.C., Hughes J., Shea T., Corey L.: Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med. 125, 257–264 (1996)

75. Schmulewitz L., Lecuit M. i wsp.: Splenic rupture and malignant Mediterranean spotted fever. Emerg. Infect. Dis. 14, 995–997 (2008)

76. Segura F., Antón E., Font B., Sala M., Cervantes M.: Primary HIV type-1 infection misdiagnosed as Mediterranean spotted fever. Eur. J. Clin. Microbiol. Infect. Dis. 21, 478–479 (2002)

77. Siński E., Bajer A., Welc R., Pawełczyk A., Ogrzewalska M., Behnke J.M.: Babesia microti: prevalence in wild rodents and Ixodes ricinus ticks from the Mazury Lakes District of North-Eastern Poland. Int. J. Med. Microbiol. 296 (S1), 137–143

78. Siński E., Welc-Faleciak R., Pogłód R.: Babesia spp. infections transmitted through blood transfusion. Wiad. Parazytol. 57, 77–81 (2011)

79. Skotarczak B., Rymaszewska A., Wodecka B., Sawczuk M.: Molecular evidence of coinfection of Borrelia burgdorferi sensu lato, human granulocytic ehrlichiosis agent, and Babesia microti in ticks from northwestern Poland. J. Parasitol. 89, 194–196 (2003)

80. Smolinski M. S., Hamburg M. A., Lederberg J.: Microbial threats to health: emergence, detection, and response. National Academies Press, Washington DC, 2003.

81. Stanek G., Wormser G.P., Gray J., Strle F.: Lyme borreliosis. Lancet, 379, 461–473 (2012)

82. Stańczak J., Cieniuch S., Lass A., Biernat B., Racewicz M.: Detection and quantification of Anaplasma phagocytophilum and Babesia spp. in Ixodes ricinus ticks from urban and rural environment, northern Poland, by real-time polymerase chain reaction. Exp. Appl. Acarol. 66, 63–81 (2015)

83. Stańczak J., Gabre R.M., Kruminis-Łozowska W., Racewicz M., Kubica-Biernat B.: Ixodes ricinus as a vector of Borrelia burgdorferi sensu lato, Anaplasma phagocytophilum and Babesia microti in urban and suburban forests. Ann. Agric. Environ. Med. 11, 109–114 (2004)

84. Swanson S.J., Neitzel D., Reed K.D., Belongia E.A.: Coinfections acquired from Ixodes ticks. Clin. Microbiol. Rev. 19, 708–727 (2006)

85. van Burgel N.D., Oosterloo M., Kroon F.P., van Dam A.P.: Severe course of Lyme neuroborreliosis in an HIV-1 positive patient; case report and review of the literature. BMC Neurol. 10, 117 (2010)

86. Vyas J.M., Telford S.R., Robbins G.K.: Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report. Clin. Infect. Dis. 45, 1588–1590 (2007)

87. Walker D.H., Olano J.P., Feng H.M.: Critical role of cytotoxic T lymphocytes in immune clearance of rickettsial infection. Infect. Immun. 69, 1841–1846 (2001)

88. Walker D.H.: Rickettsiae and rickettsial infections: the current state of knowledge. Clin. Infect. Dis. 45 (S1), 39–44 (2007)

89. Welc-Falęciak R., Bajer A., Bednarska M., Paziewska A., Siński E.: Long term monitoring of Babesia microti infection in BALB/c mice using nested PCR. Ann. Agric. Environ. Med. 14, 287–290 (2007)

90. Welc-Falęciak R., Bajer A., Paziewska-Harris A., Baumann-Popczyk A., Siński E.: Diversity of Babesia in Ixodes ricinus ticks in Poland. Adv. Med. Sci. 57, 364–369 (2012)

91. Welc-Falęciak R., Kowalec M., Karbowiak G., Bajer A., Behnke J.M., Siński E.: Rickettsiaceae and Anaplasmataceae infections in Ixodes ricinus ticks from urban and natural forested areas of Poland. Parasit. Vectors, 7; 121 (2014)

92. World Health Organizations, HIV/AIDS Global Health Observatory (GHO) data, http://www.who.int/gho/hiv/epidemic_status/deaths/en/ (styczeń 2018 r.)

93. Wodecka B.: Detection of Borrelia burgdorferi sensu lato DNA in Ixodes ricinus ticks in North-western Poland. Ann. Agric. Environ. Med. 10, 171–178 (2003)

94. Wormser G.P., Prasad A., Neuhaus E., Joshi S., Nowakowski J., Nelson J., Mittleman A., Aguero-Rosenfeld M., Topal J., Krause P.J.: Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. Clin. Infect. Dis. 50, 381–386 (2010)

95. Wormser G.P., Ramanathan R., Nowakowski J., McKenna D., Holmgren D., Visintainer P., Dornbush R., Singh B., Nadelman R.B.: Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 138, 697–704 (2003)

96. Wormser GP, Nadelman RB i wsp.: The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43, 1089–1134 (2006)

97. Wójcik-Fatla A., Zając V., Sawczyn A., Sroka J., Cisak E., Dutkiewicz J.: Infections and mixed infections with the selected species of Borrelia burgdorferi sensu lato complex in Ixodes ricinus ticks collected in eastern Poland: a significant increase in the course of 5 years. Exp. Appl. Acarol. 68, 197–212 (2016)

98. Zajkowska J., Dunaj J.: Borelioza z Lyme. Diagnostyka laboratoryjna, trudności i wyzwania. Forum Zakażeń, 4, 223–251 (2013)